BMO Capital raised the firm’s price target on Bath & Body Works to $55 from $50 and keeps an Outperform rating on the shares after its Q1 earnings beat. The company is progressing exactly as one would hope a turn would look, providing more comfort in the outlook for the second half and further improvement, the analyst tells investors in a research note. The results continue to suggest that Bath & Body Works is under-earning and that its valuation trough should increase into the double-digit earnings multiple range, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- BBWI Earnings: Bath & Body Works Plunges on Dismal Outlook
- Bath & Body Works sees FY24 free cash flow $675M-$775M
- Bath & Body Works Q1 Performance and 2024 Outlook
- Options Volatility and Implied Earnings Moves Today, June 04, 2024
- Bath & Body Works narrows FY24 EPS view to $3.05-$3.35 from $3.00-$3.35